Swiss medical-aesthetics company Teoxane is dropping its pursuit of Revance Therapeutics, paving the way for Crown Laboratories to complete its takeover of the biotechnology company. Teoxane, which ...
With the Fed's two-day FOMC meeting concluding yesterday, no offerings were priced in the IG primary, leaving weekly IG issuance so far to date at US$11.67bn, according to IFR data. But that will ...
Sanofi S.A. Part Cert-1.97% €8.03M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback